Clinical Trial Update: Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients [NA]

View source ↗

Summary

This entry notes a clinical trial investigating a combination of anti-IL6R therapy and anticoagulation in advanced nasopharyngeal carcinoma, with the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Nasopharyngeal Carcinoma | NA | Status: UNKNOWN